baber/WOPTO huggingface dataset:
Patent EP-0956202-A1 (EP)
Inventor: LAKES A DALE
IPC: G03G7/00
Filed: 1998-01-12
Abstract: A security document is provided containing a color-forming composition having an insulating material therein which allows the document to be passed through heated printing devices such as laser printers without the problem of premature color development. The color-forming composition includes a mixture of a color former, a color developer, and an insulating material. In a preferred embodiment, a toner adhesion-enhancing composition containing an insulating material is applied over the color-forming composition. The security document may be used to provide an authentication feature and/or an indication of attempted alterations from the use of solvents, heat or abrasion.
Patent EP-0963672-A1 (EP)
Inventor: VAARA TOMI
IPC: H04W8/20
Filed: 1998-02-13
Abstract: It is difficult for mobile communication networks, that provide special services tailored to individual mobile station subscribers, to direct the mobile station subscriber to an area offering this special service. The invention relates to a handover method and a call setup method in a mobile communication system which consists of base stations (BTS) and mobile stations (MS), and in which a mobile station subscriber-specific special cell list has been created for at least some of the mobile stations, the said list including the identifier for at least one cell that offers special service to the mobile station. It is characteristic for the handover method according to the invention that the cell to be assigned to the mobile station (MS) is selected on the basis of the measurement results and the special cell list, and the selected cell is set as the target cell of the handover for the mobile station. It is characteristic to the call setup method according to the invention that the cell to be assigned to the mobile station (MS) is selected on the basis of the measurement results and the special cell list, and the traffic channel for the mobile station (MS) is assigned from the base station of the selected cell.
Patent EP-0938276-A1 (EP)
Title: Filtre vasculaire
Inventor: YADAV JAY S
IPC: A61B17/12
Filed: 1998-02-03
Abstract: La présente invention a trait à un filtre vasculaire amovible destiné à bloquer la microembolie et la macroembolie tout en permettant la perfusion sanguine. Ce filtre comprend une membrane filtre (20), l'extrémité libre de la membrane s'appuyant fermement contre le fil directeur (10) lorsque la membrane filtre est affaissée. Le filtre est pourvu d'un dispositif lui permettant de déployer la membrane filtre à l'intérieur d'une lumière, comprenant des fils ou des tubes (30) fonctionnant avec une partie centrale mobile (40), ou renfermant à l'intérieur du fil directeur des fibres qui amènent la membrane filtre de l'état d'affaissement à celui de déploiement. La membrane filtre comprend un matériau à mailles fines, comparables à des pores, capable de bloquer l'embolie tout en permettant au sang de s'écouler normalement.
Patent EP-1012550-A1 (EP)
Inventor: TETZLAFF DAVID E
IPC: G08G1/01
Filed: 1998-02-23
Abstract: Emetteur (10) destiné à être utilisé lors de la mise à 1 d'une commande de processus industriel. Ledit émetteur comporte un capteur (18) conçu pour se coupler à un processus et assurer une sortie (19) de capteur reliée à un paramètre du processus; un modulateur (50) couplé à la sortie (19) du capteur et fournissant en réponse une sortie (52) numérique de train de bits représentative de la sortie (19) du capteur; un filtre (54) assurant une sortie de décimation courante; un comparateur (56) comparant une sortie de décimation préalable à la sortie de décimation courante; un circuit (28) utilisé pour émettre une sortie reliée au paramètre basé sur la décimation courante.
Patent EP-0971651-A1 (EP)
Title: Hip joint endoprosthesis
Inventor: KELLER ARNOLD
IPC: A61F2/36
Filed: 1998-03-02
Abstract: The invention concerns a hip joint endoprosthesis comprising a shank (1) to be anchored in the femur and a joint head (4) supported by the shank via a neck. In order to be able to use the same prosthesis when selecting different resection planes within the head neck during implantation, this prosthesis displays the following features: 1) the shank (1) is curved substantially uniformly in an arc; 2) the neck (3) adjoins the upper end of the shank (1) in a substantially equiaxial manner; 3) the length of the shank (1) is a maximum of 150 mm; and 4) the prosthesis is available with the same shank shape but different neck lengths, several of which are shorter than the length of an average natural femur neck.
Patent EP-0923661-A1 (EP)
Inventor: HEEKS GRAHAM
IPC: E01F9/529
Filed: 1998-03-12
Abstract: A road traffic speed control device (D) which may be placed in a road, is produced from a resiliently deformable material, so that vehicles travelling within an intended speed limit cause the device (D) to deflate, minimising any inconvenience for road users. The device (D) may be produced from a extruded or compressed partially recyclable rubber compound, with perforations or apertures (3) within it to permit deflation. Valve means (13, fig. 5), in addition to or instead of the apertures (3), may be provided in the side walls to permit reinflation, and a helical spring (5, fig. 1) within the device (D) assists in the retention of the device's shape. The device (D) may be formed so that the reinflation of the device (D) is delayed until the rear wheels of a vehicle have also passed over it.
Patent EP-1005345-A1 (EP)
Title: Procede et compositions destines au traitement d'asthme allergique et d'autres affections au moyen de descarboethoxyloratadine
Inventor: HANDLEY DEAN A
IPC: A61K31/445
Filed: 1998-02-10
Abstract: L'invention concerne des procédés employant de la descarboéthoxyloratadine ('DCL') pour traiter des affections allergiques, qui permettent de remédier à des inconvénients concomitants d'effets secondaires indésirables associés à d'autres antihistaminiques non sédatifs. L'invention concerne également des procédés destinés au traitement d'asthme allergique au moyen de DCL et d'un décongestionnant ou d'un inhibiteur de leucotriène, qui permettent de remédier à des inconvénients concomitants d'effets secondaires indésirables associés à d'autres antihistaminiques non sédatifs. L'invention a également trait à l'administration de DCL par pulvérisation nasale ou orale.
Patent EP-0976745-A1 (EP)
Inventor: NAKAZATO ATSURO
IPC: C07D409/14
Filed: 1998-03-25
Abstract: A 4-tetrahydropyridylpyrimidine derivative represented by
formula (I):
 
wherein Ar represents a phenyl group substituted with 1 to 3
substituents selected from a halogen atom, an alkyl group having
1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms,
and a trifluoromethyl group, a phenyl group, a thienyl group or a
furanyl group; R 1  represents a hydrogen atom, an alkyl group having
1 to 5 carbon atoms, an amino group or an amino group substituted
with 1 or 2 alkyl groups having 1 to 5 carbon atoms; R 2  represents
an alkyl group having 1 to 5 carbon atoms, a cycloalkylalkyl group
having 4 to 7 carbon atoms, an alkenyl group having 2 to 5 carbon
atoms or an alkynyl group having 2 to 5 carbon atoms; and X 1 , X 2 ,
and X 3 , which may be the same or different, each represent a hydrogen
atom, a halogen atom, an alkyl group having 1 to 5 carbon atoms,
an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having
1 to 5 carbon atoms, an amino group or an amino group substituted
with 1 or 2 alkyl groups having 1 to 5 carbon atoms,
or a pharmaceutically acceptable salt thereof.  
     The invention provides a compound effective on diseases which
CRF is considered to participate in, such as depression, anxiety,
Alzheimer's disease, Parkinson's syndrome, Huntington's chorea,
eating disorders, hypertension, digestive diseases, drug
dependence, epilepsy, cerebral infarction, cerebral ischemia,
cerebral edema, head wounds, inflammation, and immunity-associated
diseases.
Patent EP-0979122-A1 (EP)
Inventor: MOSSERI SOLOMON
IPC: A61F2/82
Filed: 1998-03-30
Abstract: A biomedical device assembly, such as a stent, for the targeted treatment of a tissue, such as the inhibition of restentosis. The stent is coated with an antigen, which is an example of a lock. The antigen can be bound by a labelled antibody, which is an example of a key and an effector. The antibody is preferably labelled with a radioactive source. According to one method of preparing the biomedical device assembly, after the stent has been placed in the blood vessel of the subject, the antibody is injected. The antibody then binds to the antigen on the stent, thereby localizing the radioactive source to the area to be treated, for example for restenosis. Other biomedical devices, such as a coil, an artificial valve or a vascular graft, could also be used in the place of the stent. The biomedical device could be placed in a solid tissue such as a solid tumor, or another biological passageway, such as the gastrointestinal tract, an airway or the genitourinary tract.
Patent EP-1015670-A1 (EP)
Inventor: MACCULLOCH JOHN ARNOLD
IPC: C25D11/30
Filed: 1998-03-23
Abstract: Un procédé de coloration d'un article en magnésium ou en alliage à base de magnésium consiste à mettre en contact, par immersion ou pulvérisation, une surface anodisée ou oxydée de l'article avec au moins une espèce d'une fraction chromophore dans un support liquide, dans des conditions maintenant l'intégrité de ladite surface anodisée ou encore oxydée, tout en obtenant une association du ou des chromophores (directement ou par une fraction ou une espèce fixée aux chromophores) avec la surface, par une réaction ou une adsorption. L'espèce est de préférence choisie dans le groupe constitué de colorants réactifs, de colorants directs, de colorants de cuve, de colorants au souffre et en dispersion.
Patent EP-0992495-A1 (EP)
Inventor: MONSALVATJE LLAGOSTERA MONTSER
IPC: C07D217/26
Filed: 1998-05-25
Abstract: The process for obtaining quinapril hydrochloride (I)
comprises the stages of: a) hydrogenolysis of the benzyl
ester of quinapril (II) by treatment in an alcoholic
solvent, with concentrated hydrochloric acid or a solution
of hydrogen chloride in isopropanol, and hydrogenation; b)
removal of the solvent; c) addition of toluene to
precipitate the quinapril hydrochloride as a toluene
solvate; d) treatment of said solvate with a Class 3
solvent which forms a solvate of quinapril hydrochloride
from which it can be removed by drying without degrading;
and e) drying of the solvate from step d) to yield
quinapril hydrochloride (I), an antihypertensive agent.
Patent EP-0994866-A1 (EP)
Inventor: PEVARELLO PAOLO
IPC: A61K31/41
Filed: 1998-06-25
Abstract: La présente invention concerne des dérivés 5-(3-phényle-3-oxo-propyle)-1H-tétrazole représentés par la formule (I) dans laquelle chacun des groupes R et R1 étant identique ou différent, représente hydrogène, halogène, hydroxy, trifluorométhyle, cyano, nitro, phényle, benzyle, C1-C6 alkyle, C1-C6 alcoxy, C1-C6 alkylthio, SOR4 ou SO2R4 où R4 représente C1-C6 alkyle, -N(R5R6) où chacun des groupes R5 et R6 représente indépendamment hydrogène, C1-C6 alkyle, formyle ou C2-C6 acyle; R2 représente hydrogène, C1-C6 alkyle, C1-C6 alcoxy, benzyle, phényle ou un groupe -N(R7R8) où chacun des groupes R7 et R8 représente indépendamment hydrogène, C1-C4 alkyle, benzyle, phényle, ou l'un des groupes R7 et R8 représente hydrogène et l'autre représente COR9 où R9 représente hydrogène, C1-C4 alkyle, C1-C4 alcoxy, phényle ou un groupe -N(R10R11) où R10 et R11 sont chacun indépendamment, hydrogène ou C1-C4 alkyle ou pris ensemble, R2 et R3 forment un noyau carbocyclique C3-C6. La présente invention concerne également des sels pharmaceutiquement acceptables de ceux-ci qui présentent une activité inhibant une enzyme kynurénine-3-hydroxylase.
Patent EP-1020012-A1 (EP)
Inventor: SOERENSEN ERLAND
IPC: H02P9/14
Filed: 1998-09-29
Abstract: L'invention a trait à une machine électrique rotative, du type à courant alternatif, conçue pour être directement connectée à un réseau de distribution ou de transmission. L'enroulement de la machine comprend au moins un conducteur électrique, une première couche à propriétés semi-conductrices entourant le conducteur, une couche isolante solide entourant cette première couche et une seconde couche à propriétés semi-conductrices entourant la couche isolante. Un circuit d'excitation sans balais, commutable d'une excitation positive à une excitation négative, sert à exciter cette machine. Une centrale électrique peut être pourvue de cette machine électrique rotative. Selon une technique d'excitation de la machine électrique rotative par un courant d'excitation de sens à la fois positif et négatif, on connecte momentanément aux bornes de l'enroulement inducteur (4) de la machine un dispositif bidirectionnel de protection contre les surtensions survenant au niveau du champ (8, 10, 12, 14) ou un circuit bidirectionnel de décharge.
Patent EP-1024837-A1 (EP)
Inventor: ERIKSEN MORTEN
IPC: A61K49/22
Filed: 1998-10-21
Abstract: A combined preparation comprising: i) an ultrasound contrast agent capable of accumulation in tissue microvasculature; and ii) a pharmacologically effective amount of a vasodilator drug may be used in perfusion imaging, especially of the myocardium. The contrast agent accumulates in tissue in concentrations related to the regional rate of tissue perfusion, and the vasodilator drug enhances distinction between normally perfused and underperfused tissue.
Patent EP-1011864-A1 (EP)
Inventor: SMITH DOUGLAS H
IPC: C12M1/00
Filed: 1998-09-30
Abstract: Apparatus are disclosed that thermally cycles samples between at least two temperatures. These apparatus operate by impinging fluid jets onto the outer walls of a sample containing region. Because the impinging fluid jets provide a high heat transfer coefficient between the jet and the sample containing region, the sample containing regions are uniformly cycled between the two temperatures. The heat exchange rate between the jets and the sample regions are substantially uniform.
Patent EP-1021537-A1 (EP)
Inventor: SCHRAVEN BURKHART
IPC: C12N15/09
Filed: 1998-10-13
Abstract: L'invention concerne des molécules d'acide nucléique codant pour des protéines qui s'associent au complexe du récepteur des lymphocytes T et qui ont été dénommées TRAM-1 et TRAM-2. Outre ces molécules, l'invention concerne également des molécules d'acide nucléique antisens, des vecteurs d'expression recombinants contenant une molécule d'acide nucléique de l'invention, des cellules hôtes dans lesquelles ont été introduits des vecteurs d'expression et des animaux transgéniques non humains porteurs d'un transgène TRAM. L'invention concerne aussi des protéines et des peptides TRAM-1 et TRAM-2, des protéines de fusion TRAM-1 et TRAM-2 et des anticorps anti-TRAM-1 et anti-TRAM-2. L'invention concerne enfin des techniques qui permettent d'utiliser les compositions de TRAM de l'invention, notamment des techniques qui permettent de détecter une activité TRAM dans un échantillon biologique, des techniques qui permettent de moduler l'activité TRAM dans une cellule et des techniques qui permettent d'identifier des agents pouvant moduler une interaction entre une protéine TRAM et les molécules des lymphocytes T.
Patent EP-0951991-A1 (EP)
Inventor: YANO SHINJI
IPC: C08J7/043
Filed: 1998-11-11
Abstract: An adhesive polyester film which comprises a biaxially
oriented polyester film base layer and an adhesive layer and
which is particularly useful as a base layer for a
sublimation-type thermosensitive image transfer recording
material. This base layer has no point at which the gradient
of its temperature-dimensional change curve changes from a
positive value to a negative value when temperature is
elevated from the glass transition temperature of the
polyester to 240°C and does not show a dimensional change
of more than 5 %. 
     The adhesive layer is made from (i) a water-soluble or
water-dispersible resin of a polyester modified by a vinyl
resin or (ii) a crosslinked resin of a mixture of a
water-soluble or water-dispersible acrylic resin, a
water-soluble or water-dispersible polyester resin and an
epoxy resin crosslinking agent.
Patent EP-1017814-A1 (EP)
Inventor: SKERRA ARNE
IPC: C12N15/12
Filed: 1998-09-25
Abstract: Anticalins (I) are prepared from polypeptides (II) of the lipocalin family by mutation of amino acids in the region of the 4 peptide loops (at one end of the cylindrical 'leaflet'structure). (I) can bind to a predetermined ligand with determinable affinity. An Independent claim is also included for preparation of (I).
Patent EP-1037905-A1 (EP)
Inventor: WEBBER STEPHEN E
IPC: C07D233/70
Filed: 1998-12-15
Abstract: Picornaviral 3C protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of picornaviral 3C proteases. These compounds, as well as pharmaceutical compositions that contain these compounds, are suitable for treating patients or hosts infected with one or more picornaviruses. Several novel methods and intermediates can be used to prepare the novel picornaviral 3C protease inhibitors of the present invention.
Patent EP-1042123-A1 (EP)
Inventor: MOHRMANN HANS DIERK
IPC: B41F31/30
Filed: 1998-12-22
Abstract: L'invention concerne un rouleau comprenant plusieurs balles d'encrage, qui se caractérise en ce qu'un palier d'appui est disposé entre lesdits balles d'encrage.
Patent EP-1035453-A1 (EP)
Inventor: BOSSEL CHRISTOPHE
IPC: G04B19/12
Filed: 1999-03-05
Abstract: The system uses stamped holes in the dial to ensure accurate alignment of markers on the face.  The dial (1) for a clock or watch comprises a plate in which a number of apertures (6) are provided. Each aperture is intended to receive a decorative element (8). The apertures each have a base defined by an adhesive ribbon (16) whose adhesive surfaces makes contact with the decorative element. The adhesive ribbon is glued to the reverse side of the dial over an area which is larger than that of the aperture. The adhesive tape may be of the order of 50 micro-meters thick, and may also be adhesive on both sides. The apertures in the dial may be formed by stamping the sheet material.
Patent EP-1091334-A1 (EP)
Inventor: DELBRUECK TOBIAS
IPC: G08G1/005
Filed: 1999-10-08
Abstract: A device (2) for controlling a physical system,
such as a flow of pedestrians, in an extended area
is suggested. In comprises a plurality of identical cell
units (1) with preferably hexagonal shape. The cell units
(1) are assembled in tile-like manner to form a floor.
Each cell unit is equipped with a weight sensor, lamps of
different colours, and optical communication means as
well as power connectors for connecting it to its neighbouring
cells. The cell units can be programmed to generate
signals that control the physical system, such as
signs understood by the pedestrians. Due to its modularity
and simple design, the device is easy to install and
maintain.
Patent EP-1031617-A1 (EP)
Inventor: KIKUCHI HIROAKI
IPC: C09J5/02
Filed: 1999-10-22
Abstract: A surface material 53 is provided with a first adhesive
layer 55 formed by applying a first adhesive composed of a
soluble self-digesting adhesive to an adhesive surface 531 and
a second adhesive layer 57A formed by applying a second adhesive
composed of a two-part synthetic resin contact adhesive to the
upper surface of the first adhesive layer 55. A base material
51 is provided with a base material adhesive layer 57B formed
by applying a second adhesive composed of a two-part synthetic
resin contact adhesive to an adhesive surface, and having a
composition of adhering the second adhesive layer 57A of the
surface material 53 and the base material adhesive layer 57B
of the base material 51.
Patent EP-0997659-A1 (EP)
Inventor: YAMAMOTO YASUSHI
IPC: B60W10/10
Filed: 1999-10-27
Abstract: A clutch control arrangement (1) designed to prevent unintentional
starting of a vehicle while a clutch-stroke-position learning is being
performed. The clutch control arrangement (1) includes a mechanism
(2,7,35,62,64,68,70,72,73,78,79,80,a) for automatically disengaging and
engaging a clutch (8). The vehicle has a manual transmission (76) of which
gear position (shift position) is changed as a driver operates a shift lever
(95). The clutch control arrangement (1) further includes a learning unit
for learning a stroke position of the clutch (8), and a unit (72) for
interrupting the operation of the learning unit when the shift lever (95) is
operated toward a transmission gear engaged position during the
clutch-stroke-position learning. Preferably, the automatic disengagement
and engagement mechanism automatically disengages or engages the
clutch (8) depending upon a gear engaged condition of the manual
transmission (76) after interrupting the clutch-stroke-position learning. The
clutch (8) is maintained in a disengaged condition until a clutch pedal (9) is
stamped after the automatic clutch disengagement.
Patent EP-1038961-A1 (EP)
Inventor: JONARD GERARD
IPC: C07K14/08
Filed: 1999-03-16
Abstract: The present invention concerns a method for
inducing resistance to a virus comprising a TGB2 sequence
into a cell plant or a plant, comprising the following
steps :
     preparing a nucleotide construct comprising a nucleotide
sequence corresponding to at least 70% of the nucleotide
sequence of TGB2 of said virus or its complementary cDNA,
being operably linked to one or more regulatory
sequence(s) active in a plant,   transforming a plant cell with the nucleotide construct,
and possibly   regenerating a transgenic plant from the transformed
plant cell.   
     The present invention is also related to the
plant obtained.
Patent EP-0945858-A1 (EP)
Inventor: DOI TAKANORI
IPC: G11B5/73
Filed: 1999-03-25
Abstract: A process for producing a magnetic recording medium
according to the present invention, which process
comprises:
   (a) forming on a plastic substrate, a nickel oxide
layer having a plane (200) which is
predominantly oriented in parallel with the
surface of the plastic substrate;   (b) forming on the nickel oxide layer, a cobalt-containing
magnetite film having a plane (400)
which is predominantly oriented in parallel
with the surface of the plastic substrate, at a
substrate temperature of less than 240°C; and   (c) oxidizing the obtained cobalt-containing
magnetite film in a plasma-activated oxygen
atmosphere containing a rare gas at a substrate
temperature of less than 240°C, thereby
producing a cobalt-containing maghemite film as
a perpendicular magnetic film having a spacing
of a plane (400) of not more than 0.2082 nm
(2.082 Å).    
     Such the obtained magnetic recording medium is
suitable for providing a magnetic recording medium for
high-density recording using a plastic substrate.
Patent EP-0961224-A1 (EP)
Inventor: MANCUSO MASSIMO
IPC: G06T5/00
Filed: 1999-05-25
Abstract: A system and method for reducing noise using recursive noise level
estimation. The system and method for noise reduction substitute a target pixel in a
processing window with a weighted average of a plurality of neighboring pixels
according to the degree of similarity between the target pixel and the neighboring
pixels. The similarity is based on the noise level affecting the image and the local
brightness of the processing window. The filter is based on fuzzy logic and filters out
noise without smoothing the image's fine details. The filter uses a human visual
system (HVS) response to adjust brightness.